Advertisement

Molecular Medicine

, Volume 18, Issue 3, pp 423–432 | Cite as

Low-Dose Methotrexate Inhibits Methionine S-Adenosyltransferase In Vitro and In Vivo

  • Yi-Cheng Wang
  • En-Pei Isabel Chiang
Research Article

Abstract

Methionine S-adenosyltransferase (MAT) catalyzes the only reaction that produces the major methyl donor in mammals. Low-dose methotrexate is the most commonly used disease-modifying antirheumatic drug in human rheumatic conditions. The present study was conducted to test the hypothesis that methotrexate inhibits MAT expression and activity in vitro and in vivo. HepG2 cells were cultured under folate restriction or in low-dose methotrexate with and without folate or methionine supplementation. Male C57BL/6J mice received methotrexate regimens that reflected low-dose clinical use in humans. S-adenosylmethionine and MAT genes, proteins and enzyme activity levels were determined. We found that methionine or folate supplementation greatly improved S-adenosylmethionine in folate-depleted cells but not in cells preexposed to methotrexate. Methotrexate but not folate depletion suppressed MAT genes, proteins and activity in vitro. Low-dose methotrexate inhibited MAT1A and MAT2A genes, MATI/II/III proteins and MAT enzyme activities in mouse tissues. Concurrent folinate supplementation with methotrexate ameliorated MAT2A reduction and restored S-adenosylmethionine in HepG2 cells. However, posttreatment folinate rescue failed to restore MAT2A reduction or S-adenosylmethionine level in cells preexposed to methotrexate. Our results provide both in vitro and in vivo evidence that low-dose methotrexate inhibits MAT genes, proteins, and enzyme activity independent of folate depletion. Because polyglutamated methotrexate stays in the hepatocytes, if methotrexate inhibits MAT in the liver, then the efficacy of clinical folinate rescue with respect to maintaining hepatic S-adenosylmethionine synthesis and normalizing the methylation reactions would be limited. These findings raise concerns on perturbed methylation reactions in humans on low-dose methotrexate. Future studies on the clinical physiological consequences of MAT inhibition by methotrexate and the potential benefits of S-adenosylmethionine supplementation on methyl group homeostasis in clinical methotrexate therapies are warranted.

Notes

Acknowledgments

This project was supported in part by the National Science Council (NSC98-2320-B005-004MY3 and NSC100-2628-B-005-002-MY4 to E-PI Chiang and NSC101-2911-I-005-301). This work was also supported in part by the Ministry of Education, Taiwan, R.O.C. under the Aim for Top University (ATU) plan. Both authors read and approved the final manuscript. These funding organizations were not involved in study design, data collection and analysis, decision to publish or preparation of the manuscript.

This work was presented in part at the 2008 American Association of Cancer Research Annual meeting (#3342), San Diego, CA, USA.

References

  1. 1.
    Broxson EH Jr, Stork LC, Allen RH, Stabler SP, Kolhouse JF. (1989) Changes in plasma methionine and total homocysteine levels in patients receiving methotrexate infusions. Cancer Res. 49:5879–83.PubMedGoogle Scholar
  2. 2.
    Fiskerstrand T, Ueland PM, Refsum H. (1997) Folate depletion induced by methotrexate affects methionine synthase activity and its susceptibility to inactivation by nitrous oxide. J. Pharmacol. Exp. Ther. 282:1305–11.PubMedGoogle Scholar
  3. 3.
    Selhub J, Seyoum E, Pomfret EA, Zeisel SH. (1991) Effects of choline deficiency and methotrexate treatment upon liver folate content and distribution. Cancer Res. 51:16–21.PubMedGoogle Scholar
  4. 4.
    Stempak JM, Sohn KJ, Chiang EP, Shane B, Kim YI. (2005) Cell and stage of transformation-specific effects of folate deficiency on methionine cycle intermediates and DNA methylation in an in vitro model. Carcinogenesis. 26:981–90.CrossRefPubMedGoogle Scholar
  5. 5.
    Singh R, et al. (2006) Methotrexate induced differentiation in colon cancer cells is primarily due to purine deprivation. J. Cell. Biochem. 99:146–55.CrossRefPubMedGoogle Scholar
  6. 6.
    Nesher G, Moore TL, Dorner RW. (1991) In vitro effects of methotrexate on peripheral blood monocytes: modulation by folinic acid and S-adenosylmethionine. Ann. Rheum. Dis. 50:637–41.CrossRefPubMedGoogle Scholar
  7. 7.
    Mato JM, Alvarez L, Ortiz P, Pajares MA. (1997) S-adenosylmethionine synthesis: molecular mechanisms and clinical implications. Pharmacol. Ther. 73:265–80.CrossRefPubMedGoogle Scholar
  8. 8.
    Kotb M, et al. (1997) Consensus nomenclature for the mammalian methionine adenosyltransferase genes and gene products. Trends Genet. 13:51–2.CrossRefPubMedGoogle Scholar
  9. 9.
    Halim AB, LeGros L, Geller A, Kotb M. (1999) Expression and functional interaction of the catalytic and regulatory subunits of human methionine adenosyltransferase in mammalian cells. J. Biol. Chem. 274:29720–5.CrossRefPubMedGoogle Scholar
  10. 10.
    Okada G, Teraoka H, Tsukada K. (1981) Multiple species of mammalian S-adenosylmethionine synthetase. Partial purification and characterization. Biochemistry. 20:934–40.CrossRefPubMedGoogle Scholar
  11. 11.
    Cabrero C, Puerta J, Alemany S. (1987) Purification and comparison of two forms of S-adenosyl-L-methionine synthetase from rat liver. Eur. J. Biochem. 170:299–304.CrossRefPubMedGoogle Scholar
  12. 12.
    Sullivan DM, Hoffman JL. (1983) Fractionation and kinetic properties of rat liver and kidney methionine adenosyltransferase isozymes. Biochemistry. 22:1636–41.CrossRefPubMedGoogle Scholar
  13. 13.
    Mato JM, Corrales FJ, Lu SC, Avila MA. (2002) S-adenosylmethionine: a control switch that regulates liver function. FASEB J. 16:15–26.CrossRefPubMedGoogle Scholar
  14. 14.
    Gil B, et al. (1996) Differential expression pattern of S-adenosylmethionine synthetase isoenzymes during rat liver development. Hepatology. 24:876–81.PubMedGoogle Scholar
  15. 15.
    Wang YC, Chiang EP. (2008) The effects of methotrexate and folate restriction on methionine metabolism in vitro and in vivo. Proc. FASEB 4738.Google Scholar
  16. 16.
    Chiang EP, Wang YC, Tang FY. (2007) Folate restriction and methylenetetrahydrofolate reductase 677T polymorphism decreases adoMet synthesis via folate-dependent remethylation in human-transformed lymphoblasts. Leukemia. 21:651–8.CrossRefPubMedGoogle Scholar
  17. 17.
    Wang YC, Chen YM, Lin YJ, Liu SP, Chiang EP. (2011) GNMT expression increases hepatic folate contents and folate-dependent methionine synthase-mediated homocysteine remethylation. Mol. Med. 17:486–94.PubMedCentralPubMedGoogle Scholar
  18. 18.
    Weisman MH, et al. (2006) Risk genotypes in folate-dependent enzymes and their association with methotrexate-related side effects in rheumatoid arthritis. Arthritis Rheum. 54:607–12.CrossRefPubMedGoogle Scholar
  19. 19.
    Anguera MC, et al. (2006) Regulation of folate-mediated one-carbon metabolism by 10-formyl-tetrahydrofolate dehydrogenase. J. Biol. Chem. 281:18335–42.CrossRefPubMedGoogle Scholar
  20. 20.
    Chiang EP, Wang YC, Chen WW, Tang FY. (2009) Effects of insulin and glucose on cellular metabolic fluxes in homocysteine transsulfuration, remethylation, S-adenosylmethionine synthesis, and global deoxyribonucleic acid methylation. J. Clin. Endocrinol. Metab. 94:1017–25.CrossRefPubMedGoogle Scholar
  21. 21.
    Sohn KJ, et al. (2009) The methylenetetrahydrofolate reductase C677T mutation induces cell-specific changes in genomic DNA methylation and uracil misincorporation: a possible molecular basis for the site-specific cancer risk modification. Int. J. Cancer. 124:1999–2005.CrossRefPubMedGoogle Scholar
  22. 22.
    Kremer JM, Galivan J, Streckfuss A, Kamen B. (1986) Methotrexate metabolism analysis in blood and liver of rheumatoid arthritis patients. Association with hepatic folate deficiency and formation of polyglutamates. Arthritis Rheum. 29:832–5.CrossRefPubMedGoogle Scholar
  23. 23.
    Chang HY, Tzen JT, Lin SJ, Wu YT, Chiang EP. (2010) Long-term prednisolone treatments increase bioactive vitamin B6 synthesis in vivo. J. Pharmacol. Exp. Ther. 337:102–9.CrossRefPubMedGoogle Scholar
  24. 24.
    Hartog A, Hulsman J, Garssen J. (2009) Locomotion and muscle mass measures in a murine model of collagen-induced arthritis. BMC Musculoskelet. Disord. 10:59.CrossRefPubMedGoogle Scholar
  25. 25.
    Paulos CM, et al. (2006) Folate-targeted immunotherapy effectively treats established adjuvant and collagen-induced arthritis. Arthritis Res. Ther. 8:R77.CrossRefPubMedGoogle Scholar
  26. 26.
    Saadat F, et al. (2005) Effect of pyrimethamine in experimental rheumatoid arthritis. Med. Sci. Monit. 11:BR293–9.PubMedGoogle Scholar
  27. 27.
    Chiang EP, Selhub J, Bagley PJ, Dallal G, Roubenoff R. (2005) Pyridoxine supplementation corrects vitamin B6 deficiency but does not improve inflammation in patients with rheumatoid arthritis. Arthritis. Res. Ther. 7:R1404–11.CrossRefPubMedGoogle Scholar
  28. 28.
    Chiang EP, et al. (2005) Inflammation causes tissue-specific depletion of vitamin B6. Arthritis Res. Ther. 7:R1254–62.CrossRefPubMedGoogle Scholar
  29. 29.
    Chiang EP, Bagley PJ, Selhub J, Nadeau M, Roubenoff R. (2003) Abnormal vitamin B(6) status is associated with severity of symptoms in patients with rheumatoid arthritis. Am. J. Med. 114:283–7.CrossRefPubMedGoogle Scholar
  30. 30.
    Chiang EP, Bagley PJ, Roubenoff R, Nadeau M, Selhub J. (2003) Plasma pyridoxal 5′-phosphate concentration is correlated with functional vitamin B-6 indices in patients with rheumatoid arthritis and marginal vitamin B-6 status. J. Nutr. 133:1056–9.CrossRefPubMedGoogle Scholar
  31. 31.
    Chen DY, et al. (2011) Blood lipid profiles and peripheral blood mononuclear cell cholesterol metabolism gene expression in patients with and without methotrexate treatment. BMC Med. 9:4.CrossRefPubMedGoogle Scholar
  32. 32.
    Gil B, Pajares MA, Mato JM, Alvarez L. (1997) Glucocorticoid regulation of hepatic S-adenosylmethionine synthetase gene expression. Endocrinology. 138:1251–8.CrossRefPubMedGoogle Scholar
  33. 33.
    Nesher G, Moore TL. (1990) The in vitro effects of methotrexate on peripheral blood mononuclear cells. Modulation by methyl donors and spermidine. Arthritis Rheum. 33:954–9.CrossRefPubMedGoogle Scholar
  34. 34.
    Henderson GB. (1990) Folate-binding proteins. Annu. Rev. Nutr. 10:319–35.CrossRefPubMedGoogle Scholar
  35. 35.
    Antony AC, Kane MA, Portillo RM, Elwood PC, Kolhouse JF. (1985) Studies of the role of a particulate folate-binding protein in the uptake of 5-methyltetrahydrofolate by cultured human KB cells. J. Biol. Chem. 260:14911–7.PubMedGoogle Scholar
  36. 36.
    Kane MA, Waxman S. (1989) Role of folate binding proteins in folate metabolism. Lab. Invest. 60:737–46.PubMedGoogle Scholar
  37. 37.
    Zhao R, Gao F, Goldman ID. (2001) Marked suppression of the activity of some, but not all, antifolate compounds by augmentation of folate cofactor pools within tumor cells. Biochem. Pharmacol. 61:857–65.CrossRefPubMedGoogle Scholar
  38. 38.
    Scrimgeour KG. (1986) Biosynthesis of polyglutamates of folates. Biochem. Cell Biol. 64:667–74.CrossRefPubMedGoogle Scholar
  39. 39.
    Balinska M, Galivan J, Coward JK. (1981) Efflux of methotrexate and its polyglutamate derivatives from hepatic cells in vitro. Cancer Res. 41:2751–6.PubMedGoogle Scholar
  40. 40.
    Prey S, Paul C. (2009) Effect of folic or folinic acid supplementation on methotrexate-associated safety and efficacy in inflammatory disease: a systematic review. Br. J. Dermatol. 160:622–8.CrossRefPubMedGoogle Scholar
  41. 41.
    Cronstein BN. (2005) Low-dose methotrexate: a mainstay in the treatment of rheumatoid arthritis. Pharmacol. Rev. 57:163–72.CrossRefPubMedGoogle Scholar
  42. 42.
    Whittle SL, Hughes RA. (2004) Folate supplementation and methotrexate treatment in rheumatoid arthritis: a review. Rheumatology. 43:267–71.CrossRefPubMedGoogle Scholar
  43. 43.
    Endresen GK, Husby G. (1999) Methotrexate and folates in rheumatoid arthritis. Tidsskr. Nor. Laegeforen. 119:534–7.PubMedGoogle Scholar
  44. 44.
    Getov I, Dimitrova Z, Petkova V. (2000) Low dose treatment with methotrexate: adverse drug reactions survey. Boll. Chim. Farm. 139:153–8.PubMedGoogle Scholar
  45. 45.
    Chamberlin ME, et al. (2000) Methionine adenosyltransferase I/III deficiency: novel mutations and clinical variations. Am. J. Hum. Genet. 66:347–55.Google Scholar
  46. 46.
    Mudd SH, et al. (2000) Isolated hypermethioninemia: measurements of S-adenosylmethionine and choline. Metabolism. 49:1542–7.CrossRefPubMedGoogle Scholar
  47. 47.
    Lu SC, et al. (2000) Changes in methionine adenosyltransferase and S-adenosylmethionine homeostasis in alcoholic rat liver. Am. J. Physiol. Gastrointest. Liver Physiol. 279:G178–85.CrossRefPubMedGoogle Scholar
  48. 48.
    Lu SC, et al. (2001) Methionine adenosyltransferase 1A knockout mice are predisposed to liver injury and exhibit increased expression of genes involved in proliferation. Proc. Natl. Acad. Sci. U. S. A. 98:5560–5.CrossRefPubMedGoogle Scholar
  49. 49.
    Santamaria E, et al. (2003) Functional proteomics of nonalcoholic steatohepatitis: mitochondrial proteins as targets of S-adenosylmethionine. Proc. Natl. Acad. Sci. U. S. A. 100:3065–70.CrossRefPubMedGoogle Scholar
  50. 50.
    Martinez-Chantar ML, et al. (2002) Spontaneous oxidative stress and liver tumors in mice lacking methionine adenosyltransferase 1A. FASEB J. 16:1292–4.CrossRefPubMedGoogle Scholar

Copyright information

© The Author(s) 2012

Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, and provide a link to the Creative Commons license. You do not have permission under this license to share adapted material derived from this article or parts of it.

The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder.

To view a copy of this license, visit (http://creativecommons.org/licenses/by-nc-nd/4.0/)

Authors and Affiliations

  1. 1.Department of Food Science and BiotechnologyNational Chung Hsing UniversityTaichung, 402Taiwan, Republic of China
  2. 2.Agricultural Biotechnology Center (ABC)National Chung Hsing UniversityTaichungTaiwan, Republic of China

Personalised recommendations